Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03650088 · ClinicalTrials.gov registry record · NA
Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03650088 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 18 participants.
The verdict
NCT03650088, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to 1) adapt a weight loss app that the Tate team has previously developed to promote PA and diet and adapt them to the needs and perspectives of those with Type 2 Diabetes (T2DM), integrate daily monitoring of BG using continuous monitoring (CGM) and self-monitoring of diet using the simplified system, and develop appropriate displays of data to facilitate comprehension and decision making, 2) develop the modified intervention and, 3) conduct a pilot and feasibility study on short-term impacts of the intervention in overweight adult patients with T2DM not treated with medications in preparation for an R01 submission.
Interventions
- BEHAVIORAL Behavioral weight loss with digital tools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-10-20 |
| Est. Completion | 2021-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03650088
The ClinicalTrials.gov registry entry for NCT03650088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral weight loss with digital tools is the first listed.
NCT03650088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03650088 about?
NCT03650088 is a clinical study titled "Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes". The purpose of this study is to 1) adapt a weight loss app that the Tate team has previously developed to promote PA and diet and adapt them to the needs and perspectives of those with Type 2 Diabetes (T2DM), integrate daily monitoring of BG using continuous monitoring (CGM) and self-monitoring of d...
What is the current status of trial NCT03650088?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-10-20. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT03650088?
The interventions under investigation include: Behavioral weight loss with digital tools (BEHAVIORAL).
Who is sponsoring clinical trial NCT03650088?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.